Novavax (NVAX) Asset Utilization Ratio (2011 - 2026)

Novavax's Asset Utilization Ratio history runs 16 years deep, the most recent figure standing at 0.48 for Q1 2026.

• In Q1 2026, Asset Utilization Ratio fell 45.5% year-over-year to 0.48; the TTM figure through Mar 2026 stood at 0.48 (down 45.5% YoY), while the FY2025 annual figure was 0.82, up 102.06% from the prior year.
• Asset Utilization Ratio was 0.48 for Q1 2026 at Novavax, down from 0.9 in the prior quarter.
• In the past five years, Asset Utilization Ratio ranged from a high of 0.99 in Q2 2023 to a low of 0.42 in Q4 2024.
• Historically, Asset Utilization Ratio has averaged 0.68 across 5 years, with a median of 0.63 in 2024.
• The sharpest annual moves came in 2025 and 2026: Asset Utilization Ratio soared 115.67% in 2025, then slumped 45.5% in 2026.
• A 5-year view of Asset Utilization Ratio shows it stood at 0.88 in 2022, then plunged by 34.97% to 0.57 in 2023, then slipped by 26.8% to 0.42 in 2024, then soared by 115.67% to 0.9 in 2025, then tumbled by 46.67% to 0.48 in 2026.
• The last three Asset Utilization Ratio figures came in at 0.48 (Q1 2026), 0.9 (Q4 2025), and 0.8 (Q3 2025), per Business Quant data.